You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Colorcon
Medtronic
McKinsey
Boehringer Ingelheim

Last Updated: September 20, 2020

DrugPatentWatch Database Preview

Patent: 6,232,122

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,232,122
Title: Inhibition of gene expression
Abstract:A method of inhibiting gene expression in is described. The method, which affects enzymatic activity in a plant, involves expressing in a plant, or a cell, cell line, tissue, or an organ thereof, a nucleotide sequence wherein the nucleotide sequence codes for an intron, or an intron fragment, of an SBE gene in a sense orientation; and wherein the nucleotide sequence does not contain a sequence that is sense to an exon sequence normally associated with the intron.
Inventor(s): Poulsen; Peter (Copenhagen, DK)
Assignee: Danisco A/S (Copenhagen, DK)
Application Number:08/983,440
Patent Claims:see list of patent claims

Details for Patent 6,232,122

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Danisco A/S (Copenhagen, DK) 2015-07-14 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Danisco A/S (Copenhagen, DK) 2015-07-14 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Danisco A/S (Copenhagen, DK) 2015-07-14 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Harvard Business School
Express Scripts
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.